Associate Professor, Dermatology, Stanford University Medical Center
Dermatology
Dr. Jean Y. Tang, MD
|
|
Give Review
Jean Tang is an expert in the field of Dermatology. She attended Stanford University School of Medicine. Stanford University School of Medicine is a one of the best medicals schools. Stanford University School of Medicine has a rank of 2 in research and a 25 in primary care She has 1 awards "CMS Meaningful Use Stage 1 Certification". Dr. Jean Y. Tang is a published doctor. She published 53 publications, including: 'Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors.' She accepts Medicare.
Publications
- Familial Skin cancer syndromes: Increased melanoma risk.
- Familial Skin cancer syndromes: Increased risk of nonmelanotic Skin cancers and extracutaneous tumors.
- Relation of statin use with non-melanoma Skin cancer: prospective results from the Women's Health Initiative.
- Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma.
- Genomic analysis of smoothened inhibitor resistance in Basal cell carcinoma.
- Smoking behavior and association of melanoma and nonmelanoma Skin cancer in the Women's Health Initiative.
- Dermatologic applications of direct-to-consumer genomic analysis.
- Automated identification of Basal cell carcinoma by polarization-sensitive optical coherence tomography.
- Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition.
- Quantifying Soft Tissue Loss in the Aging Male Face Using Magnetic Resonance Imaging.
- Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for Basal cell carcinoma.
- Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for Basal cell carcinoma prevention and therapy in patients with Basal cell ...
- The Use of Vismodegib to Shrink Keratocystic Odontogenic Tumors in Patients With Basal Cell Nevus Syndrome.
- Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma.
- Role of aspirin and non-aspirin NSAIDs in preventing Melanoma.
- Lower Skin Cancer Risk in Women with Higher Body Mass Index: The Women's Health Initiative Observational Study.
- Eczema and Sensitization to Common Allergens in the United States: A Multiethnic, Population-Based Study.
- Quantifying Soft Tissue Loss in Facial Aging: A Study in Women Using Magnetic Resonance Imaging.
- Alcohol consumption and risk of melanoma and non-melanoma Skin cancer in the Women's Health Initiative.
- Low-Fat Diet and Skin Cancer Risk: The Women's Health Initiative Randomized Controlled Dietary Modification Trial.
- Reply to aspirin is associated with lower Melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative.
- Cutaneous human papillomavirus infection and Basal cell carcinoma of the skin.
- Comment on Basal Cell Carcinoma Rebound After Cessation of Vismodegib in an Individual With Basal Cell Nevus Syndrome.
- Patient preferences for attributes of disease modifying Therapies: Results of a choice based conjoint analysis.
- Aspirin is associated with lower Melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative.
- GLI activation by atypical protein kinase C ?/? regulates the growth of Basal cell carcinomas.
- Nonmelanoma Skin Cancer Visits and Procedure Patterns in a Nationally Representative Sample: National Ambulatory Medical Care Survey 1995-2007.
- Itraconazole and arsenic trioxide inhibit hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists.
- Does a history of Eczema predict a future basal cell carcinoma?
- Vitamin D in cutaneous carcinogenesis: Part II.
- Vitamin D in cutaneous carcinogenesis: Part I.
- Sunscreen use in NCAA collegiate athletes: Identifying targets for intervention and barriers to use.
- The Evolving Conception and Management Challenges of Malignant Fibrous Histiocytoma.
- Factors Affecting Sunscreen Use and Sun Avoidance in a U.S. National Sample of Organ Transplant Recipients.
- Nanoelectroablation therapy for murine Basal cell carcinoma.
- Inhibiting the hedgehog pathway in patients with the Basal-cell nevus syndrome.
- Reliability and prevalence of digital image Skin types in the United States: results from National Health and Nutrition Examination Survey 2003-2004.
- Elucidating the role of molecular signaling pathways in the tumorigenesis of Basal cell carcinoma.
- Emerging treatments and signaling pathway inhibitors.
- Sun protective behaviors and vitamin D levels in the US population: NHANES 2003-2006.
- Menopausal Hormone Therapy and Risks of Melanoma and Nonmelanoma Skin Cancers: Women's Health Initiative Randomized Trials.
- Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma Skin cancer: post hoc analyses of the women's health initiative randomized controlled t...
- Hat, shade, long sleeves, or sunscreen? Rethinking US sun protection messages based on their relative effectiveness.
- Targeting superficial or nodular Basal cell carcinoma with topically formulated small molecule inhibitor of smoothened.
- Correlates of low bone mass in children with generalized forms of epidermolysis bullosa.
- Genotype-Phenotype Correlations among Pachyonychia Congenita Patients with K16 Mutations.
- Vitamin d3 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomas.
- High prevalence of vitamin D deficiency in patients with Basal cell nevus syndrome.
- Itraconazole, a commonly used antiFungal that inhibits Hedgehog pathway activity and cancer growth.
- Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice.
- Novel Hedgehog pathway targets against Basal cell carcinoma.
- Xeroderma pigmentosum group C in an isolated region of Guatemala.
Schools
Stanford Univ Sch Of Med
Procedures Preformed
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Destruction of Penile Lesion
Conditions Treated
- Actinic Keratosis
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
Santa Clara Valley Medical Center -
Stanford University School of Medicine
Hospital
-
VA Palo Alto Health Care System -
Stanford Health Care
Drug Facts
| NPI NUMBER | 1568536878 | |
| NPPES Provider LastName | TANG | |
| NPPES Provider FirstName | JEAN | |
| NPPES Provider ZIPCode | 940633132 | |
| NPPES Provider State | CA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 422.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1568536878 |
| Last Name Of The Provider | TANG |
| First Name Of The Provider | JEAN |
| View All |
Similar Doctors
|
|
Dr. Teresa Fu, MD |
|
|
Dr. Anthony E. Oro, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erik S. Cabral, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol S. Chan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathie P. Huang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brooks Bahr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey A. Carmel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matt P. Marinkovich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alison S. Klenk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David H. Peng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Yost, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jozef Lazar, MD
This Doctor is OpenDoctor Recommended.
|